Smithsante Pharmaceuticals Private Limited - Company Profile

It is a home appliances private limited company based in Chennai, Tamil Nadu, India, established in 2015.
2015 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Smithsante Pharmaceuticals Private Limited

Smithsante Pharmaceuticals Private Limited, a active private limited company, was established on 05 November 2015 in Chennai, Tamil Nadu, India. Engaging in specialized stores within the home appliances sector, it holds CIN: U52399TN2015PTC102910. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Mathivanan Venugopal (Whole-Time Director), Padinchakara Nirmal Kumar (Whole-Time Director), Rajiv Tandon (Whole-Time Director). Past directors included Rajiv Tandon, Govindarajan Kumar. It holds ₹1.10 M open charges and ₹0.50 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at New No.10A, Old No 10A, Left Portion, Ground Floor Gill Nagar 1St Street, Gill Nagar,, Chennai, Tamil Nadu, 600094.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U52399TN2015PTC102910

  • Registration Number

    102910

  • Incorporation Date

    05 November 2015

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 10 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1.10 M
  • Satisfied Charges ₹ 0.50 M
  • Revenue Growth **** -26.08%
  • Profit Growth **** 98.18%
  • Ebitda **** 7.05%
  • Net Worth -0.61%
  • Total Assets -34.67%
Company report

Smithsante Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Smithsante Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Smithsante Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Mathivanan Venugopal Whole-Time Director 08 Dec 2023 Current
Padinchakara Nirmal Kumar Whole-Time Director 08 Dec 2023 Current
Rajiv Tandon Whole-Time Director 01 Dec 2015 Current
Venganna Sreenish Kambil Managing Director 05 Nov 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Whole-Time Director 23 Feb 2025 Past
Pramod Abcsdd Director 18 Sep 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Smithsante Pharmaceuticals.

Smithsante Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 26.08% decrease. The company also saw a substantial improvement in profitability, with a 98.18% increase in profit. The company's net worth dipped by a decrease of 0.61%.

Smithsante Pharmaceuticals revenue growth over time
Smithsante Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -26.08%
*******
*******
*******
*******
Revenue from Operations
*******
 -25.42%
*******
*******
*******
*******
Total Assets
*******
 -34.67%
*******
*******
*******
*******
Profit or Loss
*******
 98.18%
*******
*******
*******
*******
Net Worth
*******
 -0.61%
*******
*******
*******
*******
EBITDA
*******
 7.05%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Smithsante Pharmaceuticals?

Unlock access to Smithsante Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,100,000.00

Satisfied Charges

₹500,000.00

Charges Breakdown by Lending Institutions
  • Others : 0.11 Cr
Latest Charge Details
Date Lender Amount Status
10 Mar 2025 Others ₹1.10 M Open
06 Mar 2024 Others ₹0.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Smithsante Pharmaceuticals?

Unlock and access historical data on people associated with Smithsante Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Smithsante Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smithsante Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Smithsante Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Smithsante Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Smithsante Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was completed.

  • Charges

    The activity A charge registered on 06 Mar 2024 via Charge ID 100893741 with Others was fully satisfied on 15 Mar 2025. was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 1.10 M with Charge ID 101085136 was registered on 10 Mar 2025. was documented.

  • Charges

    A charge with Others amounted to Rs. 0.50 M with Charge ID 100893741 was registered on 06 Mar 2024. was recorded as a recent event.

  • Director Appointment

    Mathivanan Venugopal was appointed as a Whole-time director was appointed as a Whole-time director on 08 Dec 2023 & has been associated with this company since 2 years 2 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Smithsante Pharmaceuticals Private Limited?

The CIN of Smithsante Pharmaceuticals Private Limited is U52399TN2015PTC102910.

Where is Smithsante Pharmaceuticals Private Limited headquartered?

Smithsante Pharmaceuticals Private Limited is headquartered at New No.10A, Old No 10A, Left Portion, Ground Floor Gill Nagar 1St Street, Gill Nagar,, Chennai, Tamil Nadu, 600094.

When was Smithsante Pharmaceuticals Private Limited incorporated?

Smithsante Pharmaceuticals Private Limited was incorporated on 05 November 2015.

Who are the current directors of Smithsante Pharmaceuticals Private Limited?

The current directors of Smithsante Pharmaceuticals Private Limited are

What is the primary industry of Smithsante Pharmaceuticals Private Limited?

The primary industry of Smithsante Pharmaceuticals Private Limited is Home Appliances.

Is Smithsante Pharmaceuticals Private Limited a listed company?

Smithsante Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Smithsante Pharmaceuticals Private Limited?

The authorized capital of Smithsante Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Smithsante Pharmaceuticals Private Limited?

The compliance status of Smithsante Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available